Publication:
Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures

1
0

Issued Date

2013

Resource Type

Article

File Type

application/pdf

ISSN

1017995X

DOI

10.3944/AOTT.2013.3065

Other identifier(s)

2-s2.0-84887577690

Rights Holder(s)

Scopus

Bibliographic Citation

Acta Orthopaedica et Traumatologica Turcica. Vol 47, No.5 (2013), p.318-322

Suggested Citation

Angthong C., Rodjanawijitkul S., Samart S., Angthong W. Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures. Acta Orthopaedica et Traumatologica Turcica. Vol 47, No.5 (2013), p.318-322. doi:10.3944/AOTT.2013.3065 Retrieved from: https://hdl.handle.net/20.500.14740/6514

Title

Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures

Author(s)

Angthong C.
 Rodjanawijitkul S.
 Samart S.
 Angthong W.

Abstract

Objective: The aim of this study was to report the prevalence of post-fracture bone mineral density (BMD) testing and osteoporosis treatment in patients admitted to the orthopedic department for lowenergy or high-energy fractures and to identify factors affecting prevalence of post-fracture BMD testing and osteoporosis treatment. Methods: A total of 265 patients aged 45 years or older admitted with low-energy or high-energy fractures were reviewed between January 2010 and May 2011. Information regarding age, gender, fracture site and history of post-fracture BMD testing and osteoporosis treatment, including data reporting experiences of attending orthopedists (young: <10, senior: >10 years of experience) were recorded. Results: Of the 265 patients (175 female, 90 male), 259 (97.7%) patients had low-energy fractures and 6 (2.3%) suffered high-energy fractures. Of 259 low-energy fractures, 99 (38.2%) underwent BMD testing and had mean total T-scores of -2.04±1.01 (proximal-femur) and -2.12±1.27 (lumbar-spine). Only one high-energy fracture patient (16.7%) underwent BMD testing, with a T-score of -1.1 (proximal- femur) and -2.7 (lumbar-spine). Eighty-six (32.5%) patients (85 low-energy fractures; 1 highenergy fracture) with diagnosis of osteopenia/osteoporosis from BMD testing were treated with calcium, vitamin D, and bisphosphonates. Bone mineral density testing was significantly higher in lowenergy fracture patients who were treated by a young orthopedist, a common fracture site (proximalfemur, distal-radius, vertebrae) or were female (p<0.05). Conclusion: Bone mineral density investigation and treatment rates are currently suboptimal. The current gap in adequate care necessitates multidisciplinary intervention in order to lessen the incidence of future fractures, particularly in patients over the age of 45. © 2013 Turkish Association of Orthopaedics and Traumatology.

Subject(s)

Bisphosphonic acid derivative
 Bone density conservation agent
 Calcium derivative
 Vitamin D
 Aged
 Article
 Bone density
 Drug combination
 Female
 Femur
 Femur fracture
 Follow up
 Fracture
 Human
 Injury
 Lumbar vertebra
 Male
 Middle aged
 Osteoporosis
 Photon absorptiometry
 Physiology
 Radiography
 Retrospective study
 Spine fracture
 Treatment outcome
 Utilization review
 Absorptiometry, Photon
 Aged
 Bone Density
 Bone Density Conservation Agents
 Calcium Compounds
 Diphosphonates
 Drug Therapy, Combination
 Female
 Femoral Fractures
 Femur
 Follow-Up Studies
 Fractures, Bone
 Humans
 Lumbar Vertebrae
 Male
 Middle Aged
 Osteoporosis
 Retrospective Studies
 Spinal Fractures
 Treatment Outcome
 Vitamin D

View online Resources

Research Projects

Organizational Units

Journal Issue

URI

https://hdl.handle.net/20.500.14740/6514

Collections

Scopus: Year 1983-2021

Endorsement

Review

Supplemented By

Referenced By